Skip to main content
. 2023 Nov 1;24(21):15875. doi: 10.3390/ijms242115875

Table 3.

Identified chemokines upregulated in the heart during CKD and the benefits of using inhibitory strategies.

Chemokine/
Chemokine Receptor
Inhibitory Strategy Species (Mice or Rats) Model Beneficial Effects References
CCL8 Anti-CCL8 in early CKD Mice Uremic cardiomyopathy induced by 5/6 nephrectomy. ↓ Attenuated infiltration of TCD4+, lymphocytes and macrophages.
↓ Cardiac remodeling.
↓ Inflammation.
↓ Cardiac dysfunction.
[52]
CXCL10 CCR2-/- mice or
Anti-CXCL10 antibody
Mice Uremic cardiomyopathy induced by 5/6 nephrectomy or intraperitoneal folate (240 mg/kg body weight). ↓ Monocyte infiltration in the heart.
↓ Cardiac alterations.
↓ Macrophage local proliferation.
↓ Cardiac hypertrophy.
↓ Cardiac dysfunction.
[53]

Abbreviations: CKD: chronic kidney disease, CCL8: C-C motif chemokine 8, CXCL10: chemokine (C-X-C motif) ligand (CXCL)10. Symbols: ↓ decrease.